Efficacy of Bimatoprost 0.03 Percent in Untreated Glaucoma and Ocular Hypertension Patients: Results from a Large Community-Based Clinical Trial

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 2, 2004, Pages 115-122

  Quinones, Richard ^a   Severin, Todd ^b   Mundorf, Thomas ^c  

^a Arbor Center for Eye Care   (United States)

^b East Bay Eye Center   (United States)

^c Presbyterian Medical Tower ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIMATOPROST;

ADULT; ARTICLE; CLINICAL TRIAL; CONJUNCTIVAL HYPEREMIA; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GLAUCOMA; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MULTICENTER STUDY; OPEN STUDY; POPULATION RESEARCH; PRESCRIPTION;

AMIDES; FEMALE; GLAUCOMA; HUMANS; INSTILLATION, DRUG; INTRAOCULAR PRESSURE; LIPIDS; MALE; MIDDLE AGED; OCULAR HYPERTENSION; TREATMENT OUTCOME;

EID: 1842474963     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/108076804773710786     Document Type: Article

References (18)

1. The AGIS Investigators. The advanced glaucoma intervention study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am. J. Ophthalmol. 130:429-440, 2000.
2. Mao, L.K., Stewart, W.C., and Shields, M.B. Correlation between intraocular pressure control and progressive glaucomatous damage in primary open-angle glaucoma. Am. J. Ophthalmol. 111:51-55, 1991.
3. Vogel, R., Crick, R.P., Newson, R.B., Shipley, M., Blackmore, H., and Bulpitt, C.J. Association between intraocular pressure and loss of visual field in chronic simple glaucoma. Br. J. Ophthalmol. 74:3-6, 1990.
4. Patel, S.C., and Spaeth, G.L. Compliance in patients prescribed eye-drops for glaucoma. Ophthalmic. Surg. 26:233-236, 1995.
5. Coons, S.J., Sheahan, S.L., Martin, S.S., Hendricks, J., Robbins, C.A., and Johnson, J.A. Predictors of medication noncompliance in a sample of older adults. Clin. Ther. 16:110-117, 1994.
6. Sherwood, M., and Brandt, J. Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure. Surv. Ophthalmol. 45(suppl 4):S361-S368, 2001.
7. Brandt, J.D., VanDenburgh, A.M., Chen, K., and Whitcup, S.M. Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP: a 3-month clinical trial. Bimatoprost Study Group 1. Ophthalmology 108:1023-1032, 2001.
8. DuBiner, H., Cooke, D., Dirks, M., Stewart, W.C., VanDenburgh, A.M., and Felix, C. Efficacy and safety of bimatoprost in patients with elevated intraocular pressure: a 30-day comparison with latanoprost. Surv. Ophthalmol. 45(suppl 4):S353-S360, 2001.
9. Gandolfi, S., Simmons, S.T., Sturm, R., Chen, K., and VanDenburgh, A.M. Bimatoprost Study Group 3. Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension. Adv. Ther. 18:110-121, 2001.
10. Noecker, R.J., Dirks, M.S., Choplin, N.T., Bernstein, P., Batoosingh, A.L., and Whitcup, S.M. Bimatoprost/Latanoprost Study Group. A six-month randomized clinical trial comparing the IOP-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma. Am. J. Ophthalmol. 135:55-63, 2003.
11. Lee, D.A., and Gornbein, J.A. Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial. Glaucoma Trial Study Group. J. Glaucoma 10:220-226, 2001.
12. Lee, D.A., Gornbein, J.A., and Abrams, C. The effectiveness and safety of brimonidine as mono-combination, or replacement therapy for patients with primary open-angle glaucoma or ocular hypertension: A post hoc analysis of an open-label community trial. J. Ocul. Pharmacol. Ther. 2000; 16:3-18, 2001.
13. American Academy of Ophthalmology. Preferred Practice Pattern,™ Primary Open-Angle Glaucoma 2000:38.
14. Odberg, T., and Riise, D. Early Diagnosis of glaucoma. II. The value of the initial examination in ocular hypertension. Acta. Ophthalmol. (Copenh.) 65:58-62, 1987.
15. Epstein, D.L., Krug, J.H., Jr, Hertzmark, E., Remis, L.L., and Edelstein, D.J. A long-term clinical trial of timolol therapy versus no treatment in the management of glaucoma suspects. Ophthalmology 96:1460-1467, 1989.
16. Kass, M.A. Timolol treatment prevents or delays glaucomatous visual field loss in individuals with ocular hypertension: a five-year, randomized, double-masked, clinical trial. Trans. Am. Ophthalmol. Soc. 87:598-618, 1989.
17. Kass, M.A., Heuer, D.K., Higginbotham, E.J., Johnson, C.A., Keltner, J.L., Miller, J.P., Parrish, R.K. II Wilson, M.R., and Gordon, M.O. A randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. The Ocular Hypertension Treatment Study. Arch. Ophthalmol. 120:701-713, 2002.
18. Palmberg, P. Answers from the ocular hypertension treatment study. Arch. Ophthalmol. 120:829-830, 2002.